Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Therapeutic targeting of EGFR-activated metabolic pathways in glioblastoma.

Expert opinion on investigational drugs - 1 Aug 2013

Gao Qinglei, Lei Ting, Ye Fei

Abstract excerpt

INTRODUCTION: The highly divergent histological heterogeneities, aggressive invasion and extremely poor response to treatment make glioblastoma (GBM) one of the most lethal and difficult cancers in humans. Among key elements driving its behavior is epidermal growth factor receptor (EGFR), however, neither traditional therapy including neurosurgery, radiation, temozolomide, nor targeted EGFR therapeutics in clinic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Brain Neoplasms
Share to ErbB Receptors

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to EGFR gene

Share to Glioblastoma

Share to Mutation

Share to Signal Transduction

Source

Identifiers

PMID: 23731170
DOI: 10.1517/13543784.2013.806484

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Therapeutic targeting of EGFR-activated metabolic pathways in glioblastoma.PMID 23731170Read ↗

Targeted therapy for malignant glioma patients: lessons learned and the road ahead.Semantic proximity Read ↗

Metabolism and signaling crosstalk in glioblastoma progression and therapy resistanceSemantic proximity Read ↗

Genetic and signaling pathway alterations in glioblastoma: relevance to novel targeted therapies.Semantic proximity Read ↗

Will kinase inhibitors make it as glioblastoma drugs?Semantic proximity Read ↗

Updated Insights on EGFR Signaling Pathways in GliomaSemantic proximity Read ↗

An Overview of EGFR Mechanisms and Their Implications in Targeted Therapies for GlioblastomaSemantic proximity Read ↗

An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatmentSemantic proximity Read ↗

Signaling pathways and therapeutic approaches in glioblastoma multiforme (Review)Semantic proximity Read ↗

Current Research Trends in GBM: Focus on the RTKsSemantic proximity Read ↗

Targeted Molecular Therapy of GBMSemantic proximity Read ↗

Glioblastoma multiforme: insights into pathogenesis, key signaling pathways, and therapeutic strategiesSemantic proximity Read ↗

Therapeutic Targets in Glioblastoma: Molecular Pathways, Emerging Strategies, and Future DirectionsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.